Is IDEXX Laboratories Stock Underperforming the Dow?
What it means
- What to watch: In pharma, a regulatory or trial setback can reprice one name overnight while the rest of the sector barely notices.
- How the stock is trading: $IDXX -3.65% in the latest session.
- Timing: It came out pre-market, so the next session was the first that could react.
Where the stock stands
$IDXX last traded at $554.98, -3.65% on the session. That puts it 28% shy of its 52-week high of $769.98 and 11% clear of its low of $500.61 — in the lower part of the range. Over the year it has ranged 54% from low to high: a wide band, so a several-percent week is just a week. These are latest-session quotes, not live prices — the live tape is on the $IDXX page.
How much coverage it is getting
Nothing else on $IDXX in the last 30 days: this is the only story Wook has filed, so there is no run to measure it against yet. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$IDXX earnings in 3 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.
What to watch next
For the receipts, the $IDXX page has the full chart, the filings and the valuation model these figures come from. Comparing how two or three outlets frame the same story is the fastest way to separate the facts from the angle. And Wook AI, up top, will happily do the math — how far $IDXX sits from its high, or how this week's coverage stacks up.
How this analysis was made
Yahoo Finance published it, and Wook filed it under Healthcare & Pharma. It reads bearish at medium severity because of “underperform” in the wording, with nothing on the bullish side to offset it. It was matched to $IDXX. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Yahoo Finance published this on September 10, 2026. $IDXX has moved +9.57% ($506.53 to $554.98). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.